NVO vs. XLF

In the year-to-date period, NVO achieves a -22.31% return, which is significantly lower than XLF's 3.54% return. Over the past 10 years, NVO has underperformed XLF with an annualized return of 11.19%, while XLF has yielded a comparatively higher 14.17% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Financial Select Sector SPDR Fund (XLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NVO Sharpe Ratio is -1.13, which is lower than the XLF Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of NVO and XLF, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

NVO's dividend yield for the trailing twelve months is around 2.45%, more than XLF's 1.43% yield.

The maximum NVO drawdown since its inception was -71.29%, smaller than the maximum XLF drawdown of -82.43%. Use the drawdown chart below to compare losses from any high point for NVO and XLF. For additional features, visit the drawdowns tool.

Novo Nordisk A/S (NVO) has a higher volatility of 16.43% compared to Financial Select Sector SPDR Fund (XLF) at 6.34%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than XLF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.